Austin W. Marxe & David M. Greenhouse’s Compugen CGEN Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-525,000	Closed	-$5.52M	–	141
2014 Q1	$5.52M	Buy	+525,000	New	+$5.78M	0.61%	54

Other funds holding CGEN

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

RIL

Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ACM

Antonetti Capital Management Naples, Florida $64M AUM 3.84% 1-Year Est. Return

MAA

Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's CGEN Position: Q2 2014 in Review

Austin W. Marxe & David M. Greenhouse sold out of Compugen (CGEN) in Q2 2014, closing a stake of 525,000 shares — an estimated $5.52M sold.

Austin W. Marxe & David M. Greenhouse first reported a position in CGEN in Q1 2014 and held it in 1 quarter. The position peaked at $5.52M in Q1 2014. 36 funds tracked by Wall St. Rank hold CGEN as of Q2 2014.

Austin W. Marxe & David M. Greenhouse reported no remaining Compugen position as of Q2 2014 after selling out during the quarter.
Austin W. Marxe & David M. Greenhouse sold 525,000 Compugen shares in Q2 2014, an estimated $5.52M.
Austin W. Marxe & David M. Greenhouse first reported a position in Compugen in Q1 2014 and held it in 1 quarter.
Austin W. Marxe & David M. Greenhouse's Compugen position peaked at $5.52M in Q1 2014.
36 funds tracked by Wall St. Rank held Compugen as of Q2 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q2 2014, filed 8 Aug 2014.